Currenc Group, Inc. (CURR )

Currency in USD Disclaimer
$1.96 -$0.43 (-17.99%)
Closed 12/20/2024
$1.73
$2.3
$1.19
$5.74

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol CURR
  • Company Currenc Group, Inc.
  • Price $1.96
  • Changes Percentage -17.99
  • Change -0.43
  • Day Low $1.73
  • Day High $2.3
  • Year High $5.74
  • Year Low $1.19
  • Market Cap $91,194,880
  • Price Avg 50 EMA (D) $1.91
  • Price Avg 200 EMA (D) $2.21
  • Exchange NASDAQ
  • Volume 1,332,273
  • Average Volume 372,992
  • Open $2.03
  • Previous Close $2.39
  • EPS -0.35
  • PE -5.60
  • Earnings Announcement 2024-11-29 12:00:34
  • Shares Outstanding $46,528,000

Company brief: CURRENC GROUP, INC. (CURR )

CURE Pharmaceutical Holding Corp., a biopharmaceutical company, focuses on the development and manufacturing of drug formulation and drug delivery technologies to enhance drug safety, efficacy, and patient adherence. It operates through two segments, Cure and Sera Labs. The company's pharmaceutical drug programs include CUREfilm Blue, a sildenafil oral thin film (OTF) for the treatment of erectile dysfunction; CUREfilm Canna, a cannabinoid product with optimized pharmacokinetic profiles using microCURE and CUREfilm technology; CUREfilm Anti-Viral, an orally bio-available anti-viral of an existing therapeutic leveraging existing pre-clinical/clinical safety and toxicity data; and CUREfilm Central Nervous System, a novel dosage form to treat mental health disorders, such as depression, PTSD, addiction disorders, obsessive compulsive disorders, and anxiety. It also sells various wellness products under its distribution partners' brands. In addition, the company develops 50,000IU and Vitamin D3 OTF for oral administration. It has a licensing agreement with Canopy Growth Corporation. The company was founded in 2011 and is headquartered in Oxnard, California.

CURR Corporation News

Income Statement